Archives
-
RIPA Lysis Buffer in uPAR–uPA Metastasis Research
2026-10-07
This overview places RIPA Lysis Buffer in the broader context of uPAR–uPA metastasis research, distinguishing vendor-described sample-preparation uses from the published evidence on small-molecule inhibition, cellular invasion, pharmacokinetics and tumor metastasis.
-
ARCA EGFP mRNA: Evidence and Limits
2026-10-06
ARCA EGFP mRNA (5-moUTP) is a polyadenylated mRNA reporter designed for direct EGFP fluorescence in mammalian-cell transfection studies. Its cap, modified uridine, and poly(A) features provide a plausible translation and stability rationale, but product-specific performance claims remain primarily dossier-based rather than independently benchmarked.
-
KN-62 and the Next Era of Calcium Signaling
2026-10-06
KN-62 offers a research-focused way to interrogate CaMKII within complex calcium signaling networks. This thought-leadership analysis connects supplier-reported findings with adjacent glioblastoma research while clarifying evidence strength, translational boundaries, and opportunities for more rigorous mechanistic studies.
-
CLCC1 and Herpesvirus Nuclear Egress Fusion
2026-10-05
A 2024 bioRxiv preprint identifies the host protein CLCC1 as an essential factor in the membrane-fusion stage of herpes simplex virus 1 nuclear egress. The study links CLCC1 loss to perinuclear capsid accumulation, reduced viral production, and impaired nuclear pore complex insertion, suggesting a shared connection between viral transport and nuclear-envelope morphogenesis.
-
ETS1, Mitophagy, and BPD: The SENP2 Axis
2026-10-04
The reference study identifies ETS1 as a transcriptional regulator that protects against experimental bronchopulmonary dysplasia by coordinating the SENP2/HSPA8/FUNDC1 pathway and limiting mitochondrial damage-associated mitophagy. Its findings provide a mechanistic framework for studying mitochondrial quality control in lung injury, while remaining preclinical and distinct from therapeutic validation.
-
CGRP/SP–Piezo2 Signaling in Trigeminal Neuralgia
2026-10-03
Liao et al. connect trigeminal root compression with neuroinflammation, calcium-dependent signaling, and mechanical allodynia through a proposed CGRP/SP–Piezo2 feedback circuit. Their rat and cell-based evidence suggests that TG neuron–Merkel cell communication contributes to peripheral sensitization, while also highlighting important limits on translation to human trigeminal neuralgia.
-
Biotin-tyramide for TSA: Workflow & Optimization
2026-10-02
Biotin-tyramide converts localized HRP activity into a durable, amplifiable biotin signal for demanding IHC, ISH, and biosensor workflows. This guide connects practical TSA optimization with a structure-switching aptamer study that achieved sensitive colorimetric BoNT detection.
-
Decitabine: A Causal Map of Gastric Cancer Epigenetics
2026-10-01
Decitabine (5-Aza-2'-deoxycytidine) can be used not only as a DNA methyltransferase inhibitor, but also as a causal perturbation tool in gastric cancer epigenetics. This article translates HNF4A methylation findings into a rigorous assay framework for measuring tumor suppressor gene reactivation, epithelial plasticity, and treatment specificity.
-
G-15: Reliable GPR30 Assay Design
2026-10-01
Learn how G-15 (SKU B5469) supports controlled estrogen signaling research, intracellular calcium mobilization assays, and PI3K/Akt pathway analysis. This scenario-based guide covers assay compatibility, dose planning, interpretation, and practical product-selection criteria.
-
Leucovorin Calcium in Gastric Cancer Assembloids
2026-09-30
Leucovorin Calcium can serve as more than a methotrexate-rescue reagent: it can help dissect folate dependence and treatment response in patient-derived gastric cancer assembloids. This article connects calcium folinate chemistry with tumor–stroma assay design, interpretation, and reproducibility.
-
EdU Flow Cytometry Assay Kits in Bladder Cancer
2026-09-30
EdU Flow Cytometry Assay Kits (Cy3) convert a short DNA-synthesis pulse into a quantitative S-phase readout that can be combined with phenotyping and cell-cycle analysis. Applied to the SOX7/DNMT3B/CYGB bladder-cancer model, the assay helps distinguish proliferation changes from broader molecular effects while supporting pharmacodynamic and genotoxicity workflows.
-
AM251 as a Causal Probe in CB1 Pain Research
2026-09-29
AM251, a selective CB1 receptor antagonist, can turn cannabidiol pain studies into causal experiments. This article connects receptor pharmacology, affective neuroscience, and assay design while defining practical limits for interpreting AM251 data.
-
Immunodominant P. vivax Epitopes for Surveillance
2026-09-29
A 2026 study combined computational antigen prioritization, peptide ELISA, multiplex serology, and conservation analysis to identify immunodominant B-cell epitopes for Plasmodium vivax surveillance. Four epitopes showed strong species-discriminating performance, while MSP9₃₈₄–₃₈₉ provided moderate discrimination of asymptomatic infection, offering a foundation for more targeted detection of hidden transmission reservoirs.
-
Syringin Enhances Sunitinib in Renal Cell Carcinoma
2026-09-28
This study identifies syringin as a potential natural-product sensitizer for sunitinib-resistant renal cell carcinoma (RCC). By combining network pharmacology, molecular docking, cellular assays, and pathway analysis, the authors connect syringin’s antiproliferative and pro-apoptotic effects with suppression of the EGFR/PI3K/Akt axis.
-
PF-573228 Workflows for FAK Signaling
2026-09-28
Use PF-573228 to test whether FAK activity connects matrix mechanics to cell signaling and behavior, with target-engagement measurements paired to functional assays. This practical guide adapts a stiffness-driven dentinogenesis study into a controlled workflow while distinguishing its findings from separate cancer and endothelial applications.